CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project introduces a novel resuscitation therapy called Controlled Automated Reperfusion of the whole body (CARL). This personalized approach aims to improve survival rates in cardiac arrest cases through innovative medical devices developed by a spin-off from Freiburg University Hospital.
Sudden cardiac arrest is one of the most frequent causes of death.
But only 3% of the patients survive out-of-hospital resuscitation, and only 18% survive in-hospital resuscitation.
Today the time-frame for successful resuscitation is only about 3 to 5 minutes after cardiac arrest.
Thereafter, with every minute a rapid decline in survival is observed, tending to “zero” beyond ten minutes of CPR.
For decades no significant improvement of the clinical outcome and no significant scientific progress…
UNIVERSITAETSKLINIKUM FREIBURG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, FREIBURG IM BREISGAU
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Netherlands, Rotterdam
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
